An enlarged prostate — also called benign prostatic hyperplasia or “BPH”
— is one of the most common health problems in men over 50.1
BPH can cause uncomfortable urinary symptoms and interfere with daily living, but
effective treatments are available. And sometimes, problems with urination are a
sign of a much more serious condition that needs prompt attention.2
So it's important to know what you're facing and how to manage it. bph&me can help,
every step of the way.
What treatment options are available?
Learn More >
Is it BPH?
Urinating frequently, especially at night… urge to urinate right away, straining
to urinate… weak stream… dribbling… leaking. In older men,
the most common cause of urinary symptoms like these is benign prostatic hyperplasia
(BPH), the medical term for an enlarged prostate.2
Effective treatments are available, so talk to your doctor about getting treated.
Learn more >
Talk to your doctor
BPH that is left untreated can cause serious problems over time, such as bladder
or kidney damage.2 And right now, your uncomfortable
symptoms may even be affecting your partner.3
Only a doctor can make an accurate diagnosis and help you find the best treatment
for you.2 Learn more >
Fenter TC, Naslund MJ, Shah MB, et al. The cost of treating the 10 most prevalent
diseases in men 50 years of age or older. Am J Manag Care. 2006;12(4 suppl):S90-S98
National Institute of Diabetes and Digestive and Kidney Diseases. Prostate enlargement:
benign prostatic hyperplasia. NIH Publication No. 07-3012. June 2006.
Shvartzman P, Borkan JM, Stoliar L, et al. Second-hand prostatism: effects of prostatic
symptoms on spouses’ quality of life, daily routines and family relationships. Family
Pract. 2001;18:610-613.
American Urological Association. AUA guideline on management of benign prostatic
hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol.
2003;170:530-547
Nickel JC. Comparison of clinical trials with finasteride and dutasteride. Rev Urol.
2004;6 Suppl 9:S31-9
Brawer MK. A multicenter study on the efficacy and safety of interstitial laser
coagulation versus α-blockade in subjects with symptomatic benign prostatic
hyperplasia: preliminary results. Rev Urol. 2005;7(suppl 9):S29-S33.
Moriyama N, Nasu K, Takeuchi T, et al. Quantification and distribution of a1-adrenoceptor
subtype mRNAs in human vas deferens: comparison with those of epididymal and pelvic
portions. Br J Pharmacol. 1997;122:1009-1014.
Kuritzky L. A primary care physician’s perspective on benign prostatic hyperplasia.
Rev Urol. 2003;5(suppl 5):S42-S48.
Wolters R, et al: Lower urinary tract symptoms: social influence is more important
than symptoms in seeking medical care. BJU Int. 2002;90:655–661.
Rosen RC, Giuliano F, Cason CC. Sexual dysfunction and lower urinary tract symptoms
(LUTS) associated with benign prostatic hyperplasia (BPH). Eur Urol 2005;47:824–837.
Ponholzer A, Madersbacher S. Lower urinary tract symptoms and erectile dysfunction;
Links for diagnosis, management and treatment. Int J Impot Res. 2007;19:544-550.
de Mey C, Michel MC, McEwen J, Moreland T. A double-blind comparison of terazosin
and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal
orthostatic stress testing. Eur Urol. 1998;33(5):481-8.
References
References